Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • March 16 2023

    First Wave BioPharma, Inc. announced the closing of its Private Placement offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.

  • March 15 2023

    Nija Davis-Pedlar, an associate of the Firm, wrote an article for Total Food Service titled: “Does Your Restaurant’s Uniform or Dress Code Policy Comply With The Law?.”

    Click here to read the article.

  • March 13 2023

    Intelligent Bio Solutions Inc. announced the closing of its Public Offering in the amount of $2,550,000. EG&S acted as counsel to the Placement Agent.

  • March 11 2023

    Nuvectis Pharma, Inc. announced the commencement of its At The Market Offering in the amount of $40,000,000.  EG&S acted as counsel to the Sales Agent.

  • March 08 2023

    JanOne, Inc. announced the closing of its Registered Direct offering in the amount of $422,000. EG&S acted as counsel to the Placement Agent.

  • March 07 2023

    Energous Corporation announced the closing of its Underwritten offering in the amount of $3,300,000.  EG&S acted as counsel to the Underwriter.

  • March 06 2023

    Freedom U.S. Markets, LLC, a wholly-owned subsidiary of Freedom Holding Corp., announced the completion of its acquisition of LD Micro from SRAX, Inc.  The transaction is valued at approximately $8,300,000.  EGS acted as counsel to Freedom U.S. Markets, LLC.

  • March 05 2023

    Biomerica, Inc. announced the closing of its Underwritten offering in the amount of $8,000,000.  EG&S acted as counsel to the Underwriter.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”